ERBB2 and neoplasm: A fully human anti-HER2/neu IgE (C6MH3-B1 IgE) restricted the growth of intraperitoneal (i.p.)tumours compared to vehicle controls and prolonged the survival of human FcεRIα-transgenic mice [160].